Sector Companies. Results in biotechnology for main variables and branches of activity

• Select values to consult
  • Main variables

    Values that contain

    No. of companies carrying out R&D in Biotechnology %Companies according to biotechnology used: Genetic code %Companies according to biotechnology used: Functional units %Companies according to biotechnology used: Cellular and tissue culturing and engineering %Companies according to biotechnology used: Bioprocesses %Companies according to biotechnology used: Sub-cellular organisms %Companies according to biotechnology used: Bio-computing %Companies according to biotechnology used: Nanobiotechnology %Companies according to biotechnology used: Other Companies in which biotechnology activities are: Main and/or exclusive Companies in which biotechnology activities are: A secondary line of business Companies in which biotechnology activities are: A tool necessary for production %Company by field(s) of ultimate application of biotechnology use: Human Health %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture %Company by field(s) of ultimate application of biotechnology use: Food products %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production %Company by field(s) of ultimate application of biotechnology use: Environment %Company by field(s) of ultimate application of biotechnology use: Industry Personnel in R&D in biotechnology (no. of persons) Personnel in R&D in biotechnology (no. of persons): Researchers Personnel in R&D in biotechnology (no. of persons): Technicians and assistants Personnel in R&D in biotechnology (no. of persons): women Personnel in R&D in biotechnology (no. of persons): (women) Researchers Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants Personnel in R&D in biotechnology (FTE) Personnel in R&D in biotechnology (FTE): Researchers Personnel in R&D in biotechnology (FTE): Technicians and assistants Personnel in R&D in biotechnology (FTE): women Personnel in R&D in biotechnology (FTE): (women) Researchers Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants Internal expenditure on R&D (thousands of euros) 1) By nature of the expense: Current expenses 1.1) Remuneration to researchers 1.2) Remuneration to technicians and assistants 1.3) Other current expenses 2) By nature of the expense: Capital expenses 2.1) Land and buildings 2.2) Equipment and instruments 2.3) Acquisition of specific R&D software 2.4) Otros productos de propiedad intelectual específicos para I+D 1.1) By origin of the funds: Own funds 1.2) By origin of the funds: From companies 1.3) By origin of the funds: Public Administration funds 1.4) By origin of the funds: From Universities 1.5) By origin of the funds: From non profit private institutions 1.6) By origin of the funds: Foreign funds Purchase of R&D services in biotechnology (thousands of euros) Purchase of R&D services in biotechnology (thousands of euros): In Spain Purchase of R&D services in biotechnology (thousands of euros): Abroad %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting % Companies that have requested biotechnology patents in Biotechnology Number of patents requested % Companies with income of an international origin related to biotechnological activities % Turnover representing income of an international origin related to biotechnological activities % Income of an international origin related to biotechnological activities distributed in: Income received from the EU % Income of an international origin related to biotechnological activities distributed in: Income received from other countries % Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain % Income of an international origin related with activities according to the classification: Operating source abroad % Income of an international origin related with activities according to the classification: Other

    Selected:69

    Total:69
  • Branches of activity

    Values that contain

    Total Companies Services Industry and Construction Agriculture

    Selected:1

    Total:4
• Choose format of the table

  • 	Branches of activity
    Main variables	.	.	.
    	.	.	.
    	.	.	.

  • Decimals to show: By default 0 1 2
• Notes
  • 1) '.'=numeric piece of data equal to zero not resulting from rounding
    
    FTE: Full Time Equivalent

• Source:National Statistics Institute